Detalhe da pesquisa
1.
Cost-effectiveness of atezolizumab versus pembrolizumab as first-line treatment in PD-L1-positive advanced non-small-cell lung cancer in Spain.
Cost Eff Resour Alloc
; 21(1): 6, 2023 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36647072
2.
Randomised Phase II study comparing alternating cycles of sunitinib and everolimus vs standard sequential administration in first-line metastatic renal carcinoma (SUNRISES study).
BJU Int
; 126(5): 559-567, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32654362
3.
Radium-223 international early access program: results from the Spanish subset.
Future Oncol
; 14(1): 41-50, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29232987
4.
Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study.
BMC Cancer
; 16: 135, 2016 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-26906039
5.
Neoadjuvant chemotherapy with dose-dense MVAC in muscle-invasive bladder cancer: a tertiary center experience.
Clin Transl Oncol
; 26(2): 549-553, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37566343
6.
Spatially preserved multi-region transcriptomic subtyping and biomarkers of chemoimmunotherapy outcome in extensive-stage small cell lung cancer.
Clin Cancer Res
; 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38630755
7.
The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy.
Clin Transl Oncol
; 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38512450
8.
Alectinib after failure to crizotinib in patients with ALK-positive non-small cell lung cancer: results from the Spanish early access program.
Oncotarget
; 13: 812-827, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35720977
9.
PD-L1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer in PD-L1 Positive Patients: A Safety Data Network Meta-Analysis.
J Clin Med
; 10(19)2021 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34640601
10.
Circulating Levels of the Interferon-γ-Regulated Chemokines CXCL10/CXCL11, IL-6 and HGF Predict Outcome in Metastatic Renal Cell Carcinoma Patients Treated with Antiangiogenic Therapy.
Cancers (Basel)
; 13(11)2021 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34200459
11.
LungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technology.
Cancer Med
; 10(17): 5878-5888, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34296539
12.
Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non-Small Cell Lung Carcinoma: the ROSING Study.
J Thorac Oncol
; 14(12): 2120-2132, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31349061
13.
Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC).
Cancer Chemother Pharmacol
; 62(2): 253-61, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17901953
14.
Chemotherapy of advanced gastric cancer.
Cancer Treat Rev
; 33(4): 315-24, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17376598
15.
Long term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in non-resectable locally advanced (stage IV-B) squamous cell head and neck carcinoma and peripheral blood stem cell support (PBSCS) with febrile neutropenia.
Clin Transl Oncol
; 9(1): 40-7, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17272229
16.
Consensus Recommendations from the Spanish Germ Cell Cancer Group on the Use of High-dose Chemotherapy in Germ Cell Cancer.
Eur Urol Focus
; 3(2-3): 280-286, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28753776
17.
Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study.
J Clin Oncol
; 23(34): 8717-23, 2005 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16260698
18.
Fibroblast growth factor receptor 3 is overexpressed in urinary tract carcinomas and modulates the neoplastic cell growth.
Clin Cancer Res
; 11(2 Pt 1): 459-65, 2005 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15701828
19.
Long-term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine, and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in a primary site preservation setting for resectable locally advanced squamous cell carcinoma of larynx and hypopharynx.
Laryngoscope
; 114(7): 1163-9, 2004 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15235341
20.
Adjuvant MAGE-A3 immunotherapy in resected non-small-cell lung cancer: phase II randomized study results.
J Clin Oncol
; 31(19): 2396-403, 2013 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23715567